Skip to main content
Top
Published in: Radiation Oncology 1/2014

Open Access 01-12-2014 | Research

First experiences with the implementation of the European standard EN 62304 on medical device software for the quality assurance of a radiotherapy unit

Authors: Angelika Höss, Christian Lampe, Ralf Panse, Benjamin Ackermann, Jakob Naumann, Oliver Jäkel

Published in: Radiation Oncology | Issue 1/2014

Login to get access

Abstract

Background

According to the latest amendment of the Medical Device Directive standalone software qualifies as a medical device when intended by the manufacturer to be used for medical purposes. In this context, the EN 62304 standard is applicable which defines the life-cycle requirements for the development and maintenance of medical device software. A pilot project was launched to acquire skills in implementing this standard in a hospital-based environment (in-house manufacture).

Methods

The EN 62304 standard outlines minimum requirements for each stage of the software life-cycle, defines the activities and tasks to be performed and scales documentation and testing according to its criticality. The required processes were established for the pre-existent decision-support software FlashDumpComparator (FDC) used during the quality assurance of treatment-relevant beam parameters. As the EN 62304 standard implicates compliance with the EN ISO 14971 standard on the application of risk management to medical devices, a risk analysis was carried out to identify potential hazards and reduce the associated risks to acceptable levels.

Results

The EN 62304 standard is difficult to implement without proper tools, thus open-source software was selected and integrated into a dedicated development platform. The control measures yielded by the risk analysis were independently implemented and verified, and a script-based test automation was retrofitted to reduce the associated test effort. After all documents facilitating the traceability of the specified requirements to the corresponding tests and of the control measures to the proof of execution were generated, the FDC was released as an accessory to the HIT facility.

Conclusions

The implementation of the EN 62304 standard was time-consuming, and a learning curve had to be overcome during the first iterations of the associated processes, but many process descriptions and all software tools can be re-utilized in follow-up projects. It has been demonstrated that a standards-compliant development of small and medium-sized medical software can be carried out by a small team with limited resources in a clinical setting. This is of particular relevance as the upcoming revision of the Medical Device Directive is expected to harmonize and tighten the current legal requirements for all European in-house manufacturers.
Appendix
Available only for authorised users
Literature
1.
go back to reference Council Directive 93/42/EEC of 14 June 1993 concerning medical devices OJ 1993, L169: 1-43. Council Directive 93/42/EEC of 14 June 1993 concerning medical devices OJ 1993, L169: 1-43.
2.
go back to reference Directive 2007/47/EC of the European parliament and of the council of 5 September 2007 amending Council Directive 90/385/EEC on the approximation of the laws of the Member States relating to active implantable medical devices, Council Directive 93/42/EEC concerning medical devices and Directive 98/8/EC concerning the placing of biological products on the market OJ 2007, L247: 21-55. Directive 2007/47/EC of the European parliament and of the council of 5 September 2007 amending Council Directive 90/385/EEC on the approximation of the laws of the Member States relating to active implantable medical devices, Council Directive 93/42/EEC concerning medical devices and Directive 98/8/EC concerning the placing of biological products on the market OJ 2007, L247: 21-55.
3.
go back to reference European Committee for Standardization: EN ISO 13485:2012. Medical devices – Quality management systems – Requirements for regulatory purposes. 2012. European Committee for Standardization: EN ISO 13485:2012. Medical devices – Quality management systems – Requirements for regulatory purposes. 2012.
4.
go back to reference European Committee for Electrotechnical Standardization: EN 62304:2006. Medical device software – Software life-cycle processes. 2006. European Committee for Electrotechnical Standardization: EN 62304:2006. Medical device software – Software life-cycle processes. 2006.
5.
go back to reference European Committee for Standardization: EN ISO 14971:2012. Medical devices – Application of risk management to medical devices. 2012. European Committee for Standardization: EN ISO 14971:2012. Medical devices – Application of risk management to medical devices. 2012.
6.
go back to reference International Electrotechnical Commission: IEC/TR 80002-1:2009. Medical device software – Part 1: Guidance on the application of ISO 14971 to medical device software. 2009. International Electrotechnical Commission: IEC/TR 80002-1:2009. Medical device software – Part 1: Guidance on the application of ISO 14971 to medical device software. 2009.
7.
go back to reference European Committee for Electrotechnical Standardization: EN 60601-1-4:1996. Medical electrical equipment: Part1–4General requirements for safety – Collateral standard: Programmable electrical medical systems. 1996. European Committee for Electrotechnical Standardization: EN 60601-1-4:1996. Medical electrical equipment: Part1–4General requirements for safety – Collateral standard: Programmable electrical medical systems. 1996.
8.
go back to reference Haberer T, Debus J, Eickhoff H, Jäkel O, Schulz-Ertner D, Weber U: The Heidelberg ion therapy center. Radiother Oncol 2004,73(Suppl 2):186-190.CrossRef Haberer T, Debus J, Eickhoff H, Jäkel O, Schulz-Ertner D, Weber U: The Heidelberg ion therapy center. Radiother Oncol 2004,73(Suppl 2):186-190.CrossRef
9.
go back to reference Combs SE, Jäkel O, Haberer T, Debus J: Particle therapy at the Heidelberg Ion Therapy Center (HIT) - Integrated research-driven university-hospital-based radiation oncology service in Heidelberg, Germany. Radiother Oncol 2010,95(1):41-44. 10.1016/j.radonc.2010.02.016CrossRefPubMed Combs SE, Jäkel O, Haberer T, Debus J: Particle therapy at the Heidelberg Ion Therapy Center (HIT) - Integrated research-driven university-hospital-based radiation oncology service in Heidelberg, Germany. Radiother Oncol 2010,95(1):41-44. 10.1016/j.radonc.2010.02.016CrossRefPubMed
10.
go back to reference Combs SE, Ellerbrock M, Haberer T, Habermehl D, Hoess A, Jäkel O, Jensen A, Klemm S, Münter M, Naumann J, Nikoghosyan A, Oertel S, Parodi K, Rieken S, Debus J: Heidelberg Ion Therapy Center (HIT): Initial clinical experience in the first 80 patients. Acta Oncol 2010,49(7):1132-1140. 10.3109/0284186X.2010.498432CrossRefPubMed Combs SE, Ellerbrock M, Haberer T, Habermehl D, Hoess A, Jäkel O, Jensen A, Klemm S, Münter M, Naumann J, Nikoghosyan A, Oertel S, Parodi K, Rieken S, Debus J: Heidelberg Ion Therapy Center (HIT): Initial clinical experience in the first 80 patients. Acta Oncol 2010,49(7):1132-1140. 10.3109/0284186X.2010.498432CrossRefPubMed
11.
go back to reference Combs SE, Kessel KA, Herfarth K, Jensen A, Oertel S, Blattmann C, Ecker S, Hoess A, Martin E, Witt O, Jäkel O, Kulozik AE, Debus J: Treatment of pediatric patients and young adults with particle therapy at the Heidelberg Ion Therapy Center (HIT): establishment of workflow and initial clinical data. Radiat Oncol 2012, 7: 170. 10.1186/1748-717X-7-170PubMedCentralCrossRefPubMed Combs SE, Kessel KA, Herfarth K, Jensen A, Oertel S, Blattmann C, Ecker S, Hoess A, Martin E, Witt O, Jäkel O, Kulozik AE, Debus J: Treatment of pediatric patients and young adults with particle therapy at the Heidelberg Ion Therapy Center (HIT): establishment of workflow and initial clinical data. Radiat Oncol 2012, 7: 170. 10.1186/1748-717X-7-170PubMedCentralCrossRefPubMed
12.
go back to reference Habermehl D, Rieken S, Ecker S, Kessel KA, Herfarth K, Debus J, Combs SE: First experiences in treatment of low-grade glioma grade I and II with proton therapy. Radiat Oncol 2012, 7: 189. 10.1186/1748-717X-7-189CrossRef Habermehl D, Rieken S, Ecker S, Kessel KA, Herfarth K, Debus J, Combs SE: First experiences in treatment of low-grade glioma grade I and II with proton therapy. Radiat Oncol 2012, 7: 189. 10.1186/1748-717X-7-189CrossRef
13.
go back to reference Rieken S, Habermehl D, Haberer T, Jaekel O, Debus J, Combs SE: Proton and carbon ion radiotherapy for primary brain tumors delivered with active raster scanning at the Heidelberg Ion Therapy Center (HIT): early treatment results and study concepts. Radiother Oncol 2012, 7: 41. 10.1186/1748-717X-7-41CrossRef Rieken S, Habermehl D, Haberer T, Jaekel O, Debus J, Combs SE: Proton and carbon ion radiotherapy for primary brain tumors delivered with active raster scanning at the Heidelberg Ion Therapy Center (HIT): early treatment results and study concepts. Radiother Oncol 2012, 7: 41. 10.1186/1748-717X-7-41CrossRef
14.
go back to reference Haberer T, Becher W, Schardt D, Kraft G: Magnetic scanning system for heavy ion therapy. Nucl Instr Meth Phys Res 1993, 330: 296-305. 10.1016/0168-9002(93)91335-KCrossRef Haberer T, Becher W, Schardt D, Kraft G: Magnetic scanning system for heavy ion therapy. Nucl Instr Meth Phys Res 1993, 330: 296-305. 10.1016/0168-9002(93)91335-KCrossRef
15.
go back to reference European Committee for Electrotechnical Standardization: EN ISO 62366:2008. Medical devices – Application of usability engineering to medical devices. 2008. European Committee for Electrotechnical Standardization: EN ISO 62366:2008. Medical devices – Application of usability engineering to medical devices. 2008.
Metadata
Title
First experiences with the implementation of the European standard EN 62304 on medical device software for the quality assurance of a radiotherapy unit
Authors
Angelika Höss
Christian Lampe
Ralf Panse
Benjamin Ackermann
Jakob Naumann
Oliver Jäkel
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Radiation Oncology / Issue 1/2014
Electronic ISSN: 1748-717X
DOI
https://doi.org/10.1186/1748-717X-9-79

Other articles of this Issue 1/2014

Radiation Oncology 1/2014 Go to the issue